Jonathan Phillips - Streamline Health Independent Chairman of the Board
| STRM Stock | USD 0.29 0.01 3.33% |
Chairman
Mr. Jonathan R. Phillips is the Independent Chairman of the Board, Director of the Company. Mr. Phillips has served as Managing Director and Head of Private Equity at First Trust Portfolios, a diversified asset management firm headquartered in Wheaton, Illinois, since November 2016. Mr. Phillips is also the founder and Managing Partner of First Health Capital Partners, LLC, a healthcare technology and services investment firm founded in January 2016. In 2005, Mr. Phillips founded Healthcare Growth Partners, a provider of strategic and financial advisory services to healthcare technology companies, and served as its Managing Director until November 2016. Prior to founding Healthcare Growth Partners, Mr. Phillips was a member of the Healthcare Investment Banking Group at William Blair and Company, LLC, an investment banking firm. Prior to William Blair, he served in various roles in the healthcare practice of Deloitte Consulting. From 2007 until immediately prior to its acquisition by Merge Healthcare Incorporated in 2011, Mr. Phillips was a director of Ophthalmic Imaging Systems, Inc., a public company that provided software and technology for ophthalmology practices, where he served on the audit, compensation, and nominating committees and chaired the special committee. Mr. Phillips also serves as a director for several private companies. Mr. Phillips currently serves on the Board of Visitors of DePauw University, on the Rush University Medical Center Associates board, and on the nonprofit board of the Ray Graham Association, where he is a member of the finance committee. Mr. Phillips is a securities principal having completed the Series 24, 7 and 63 exams since 2009.
| Age | 44 |
| Tenure | 15 years |
| Professional Marks | MBA |
| Address | 2400 Old Milton Pkwy, Alpharetta, GA, United States, 30009 |
| Phone | 888 997 8732 |
| Web | https://www.streamlinehealth.net |
Streamline Health Management Efficiency
The company has return on total asset (ROA) of (0.1144) % which means that it has lost $0.1144 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7237) %, meaning that it created substantial loss on money invested by shareholders. Streamline Health's management efficiency ratios could be used to measure how well Streamline Health manages its routine affairs as well as how well it operates its assets and liabilities. As of the 2nd of May 2024, Return On Tangible Assets is likely to drop to -0.0012. In addition to that, Return On Capital Employed is likely to drop to -0.0005. At this time, Streamline Health's Debt To Assets are very stable compared to the past year.Similar Executives
| Found 6 records | CHAIRMAN Age | ||
| Stephen Neeleman | HealthEquity | 56 | |
| Robert Selander | HealthEquity | 67 | |
| Robert Frist | HealthStream | 57 | |
| Kristian Lundkvist | National Research Corp | N/A | |
| Helge Midttun | National Research Corp | 60 | |
| G Goenka | National Research Corp | N/A | |
Management Performance
| Return On Equity | -0.72 | ||||
| Return On Asset | -0.11 |
Streamline Health Leadership Team
Elected by the shareholders, the Streamline Health's board of directors comprises two types of representatives: Streamline Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Streamline. The board's role is to monitor Streamline Health's management team and ensure that shareholders' interests are well served. Streamline Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Streamline Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ben Stilwill, President | ||
| Donald Vick, Director Analytics | ||
| Jawad Shaikh, Chief Officer | ||
| Wyche Green, Director | ||
| David Sides, CEO and President and Director | ||
| Jacob Goldberger, Director FPA | ||
| Wendy Lucio, Chief Officer | ||
| Wendy Lovvorn, Chief Officer | ||
| Lois Rickard, Chief People Officer and Sr. VP | ||
| Luciana Mullen, Principal Accounting Officer | ||
| Amy Sebero, Chief Officer | ||
| Shaun Priest, Senior Vice President and Chief Growth Officer | ||
| Bryant Reeves, Interim Staff | ||
| Wyche III, Executive Chairman | ||
| Jack Kennedy, Chief Legal Counsel and Sr. VP of Admin. | ||
| Lance Seach, Senior Development | ||
| Kenan Lucas, Director | ||
| Nicholas Meeks, CFO, Senior Vice President | ||
| Michael Valentine, Independent Director | ||
| Allen Moseley, Independent Director | ||
| Randolph Salisbury, Chief Marketing Officer and Sr. VP | ||
| Jonathan Phillips, Independent Chairman of the Board | ||
| Benjamin Stilwill, Chief Officer | ||
| William Garvis, COO, Senior Vice President | ||
| Michael Kaplan, Independent Director | ||
| Judith Starkey, Director | ||
| Thomas Gibson, CFO, Senior Vice President | ||
| MB CCS, VP eValuator |
Streamline Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Streamline Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.72 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (0.81) % | ||||
| Operating Margin | (0.71) % | ||||
| Current Valuation | (2.72 M) | ||||
| Shares Outstanding | 59.09 M | ||||
| Shares Owned By Insiders | 28.21 % | ||||
| Shares Owned By Institutions | 31.72 % | ||||
| Number Of Shares Shorted | 39.65 K | ||||
| Price To Earning | 321.67 X |
Currently Active Assets on Macroaxis
When determining whether Streamline Health is a strong investment it is important to analyze Streamline Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Streamline Health's future performance. For an informed investment choice regarding Streamline Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for Streamline Stock analysis
When running Streamline Health's price analysis, check to measure Streamline Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Streamline Health is operating at the current time. Most of Streamline Health's value examination focuses on studying past and present price action to predict the probability of Streamline Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Streamline Health's price. Additionally, you may evaluate how the addition of Streamline Health to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
Is Streamline Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Streamline Health. If investors know Streamline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Streamline Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 12.131 | Earnings Share (0.35) | Revenue Per Share 0.428 | Quarterly Revenue Growth (0.01) | Return On Assets (0.11) |
The market value of Streamline Health is measured differently than its book value, which is the value of Streamline that is recorded on the company's balance sheet. Investors also form their own opinion of Streamline Health's value that differs from its market value or its book value, called intrinsic value, which is Streamline Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Streamline Health's market value can be influenced by many factors that don't directly affect Streamline Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Streamline Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Streamline Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Streamline Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.